SITC-NCI Computational Immuno-Oncology Webinar Series: New Technologies for Clinical Decision Making and Research
In partnership with NCI’s Cancer MoonshotSM Initiative, the Society for Immunotherapy of Cancer (SITC) and the Big Data and Data Sharing Committee are hosting the second of nine webinars that make up the 2022 SITC-NCI Computational Immuno-Oncology Webinar Series. Dr. Rong Fan of Yale University will be presenting, “New Technologies for Clinical Decision Making and Research: Computational Science in Immuno-Oncology.” Discussion will be moderated by University of Virginia’s Dr. Matthew Reilley. Attendees must log in or create a free SITC account to register.
The SITC-NCI Computational Immuno-Oncology Webinar Series consists of nine, hour-long courses featuring a moderator and faculty speaker to lead instruction. Topics will cover a host of computational challenges of analyzing and integrating diverse assay data across the spectrum of immuno-oncology. This series is intended for scientists early in their career and/or those who want to remain abreast of the latest technologies. These webinars were created to foster better communication concerning data science technologies and analyses between cancer immunotherapy researchers and clinicians to advance translational immunotherapy research.
Dr. Fan is a professor of biomedical engineering and pathology at Yale School of Medicine.
Dr. Reilley is an assistant professor in the University of Virginia’s School of Medicine in the Department of Medicine, Hematology, and Oncology.
Upcoming Events
- AI-Driven Spatial Transcriptomics Unlocks Large-Scale Breast Cancer Biomarker Discovery from HistopathologyMay 07, 2025Co-clinical Imaging Research Resource Program (CIRP) Annual Virtual Meeting 2025—Celebrating A Ten-Year MilestoneMay 07, 2025 - May 08, 2025Workshop Series: Synthetic and Systems Approaches to Interrogate Spatiotemporal Processes in CancerMay 13, 2025 - May 20, 2025Pediatric Preclinical In Vivo Testing (PIVOT) Program: Advancing Targeted Therapies for Childhood CancersMay 13, 2025Agentic AI in Cancer ResearchMay 27, 2025